Immunization of HIV-infected adults in the UK with Haemophilus influenzae b/meningococcal C glycoconjugate and pneumococcal polysaccharide vaccines
U.K. guidelines for vaccinating HIV-infected adults against bacteria are based on limited data. We compared antibody responses between 211 HIV-infected and 73 HIV-uninfected adults vaccinated with pneumococcal polysaccharide vaccine (PPV) and Haemophilus influenzae b/meningococcal C polysaccharide-t...
Autors principals: | MacLennan, C, Richter, A, Hodson, J, Faustini, S, Birtwistle, J, Whitelegg, A, Chigiga, J, Singo, M, Walker-Haywood, J, Mulugeta, B, Masuka, S, Mainey, C, Plant, T, Drayson, M, Manavi, K |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Lippincott, Williams and Wilkins
2016
|
Ítems similars
-
Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
per: Snape, MD, et al.
Publicat: (2009) -
Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines
per: Francesca Micoli, et al.
Publicat: (2023-05-01) -
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
per: Micoli, F, et al.
Publicat: (2013) -
Impact and Control of Sugar Size in Glycoconjugate Vaccines
per: Giuseppe Stefanetti, et al.
Publicat: (2022-09-01) -
Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial.
per: Khatami, A, et al.
Publicat: (2011)